[Engerix B vaccine in prophylaxis of hepatitis B virus infection in children with diabetes].
Twenty children with diabetes received Engerix B vaccine against virus hepatitis B. The antibody level was studied one month after completion of accelerated vaccination course. All patients achieved protective antibody level. The number of patients with diabetes in Poland is increasing. Virus hepatitis B makes worse the prognosis. Good effects of vaccinations are the encouragement to undertaking such management in all diabetic clinics in Poland.
Tańska
A
A
Oddziału Dzieciecego Wojewódzkiego Szpitala Zespolonego w Ostrołece.
D000293:Adolescent; D002648:Child; D048909:Diabetes Complications; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000032:analysis; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D011044:Poland; D014614:Vaccines, Synthetic / Q000008:administration & dosage*
C075654:Engerix-B; D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic
Szczepionka engerix B w zapobieganiu zakazenia wirusem zapalenia watroby typu B (HBV) u dzieci chorych na cukrzyce.